JAMA internal medicine

Statins for Primary Cardiovascular Disease Prevention: Time to Curb Our Enthusiasm.

JAMA internal medicine

Habib AR, Katz MH, Redberg RF

Development and External Validation of a Mortality Prediction Model for Community-Dwelling Older Adults With Dementia.

JAMA internal medicine

Deardorff WJ, Barnes DE, Jeon SY, Boscardin WJ, Langa KM, Covinsky KE, Mitchell SL, Whitlock EL, Smith AK, Lee SJ

Intravascular Microaxial Left Ventricular Assist Device for Acute Myocardial Infarction With Cardiogenic Shock-A Call for Evidence of Benefit.

JAMA internal medicine

Hu G, Habib AR, Redberg RF

JAMA Internal Medicine-Year in Review, 2021.

JAMA internal medicine

Redberg RF

US Food and Drug Administration-Mandated Postmarketing Studies for High-risk Cardiovascular Devices Approved 2015-2019.

JAMA internal medicine

Hidano D, Dhruva SS, Redberg RF

Reporting Device-Associated Death Events to the FDA-Reply.

JAMA internal medicine

Lalani C, Kinard M, Redberg RF

FDA Regulation of Medical Devices-Moving Beyond the Horse and Buggy.

JAMA internal medicine

Holtzman J, Lalani C, Redberg RF

The Next Frontier of Less Is More-From Description to Implementation.

JAMA internal medicine

Latifi N, Redberg RF, Grady D

Conflicts of Interest and Authors of Commentaries in Medical Journals.

JAMA internal medicine

Steinbrook R, Grady D, Redberg RF

Reporting of Death in US Food and Drug Administration Medical Device Adverse Event Reports in Categories Other Than Death.

JAMA internal medicine

Lalani C, Kunwar EM, Kinard M, Dhruva SS, Redberg RF

Pages